Toxicity of targeted therapies in elderly patients. - Wikidata - wikimedia - TriplyDB

Toxicity of targeted therapies in elderly patients.

Toxicity of targeted therapies in elderly patients.

http://www.wikidata.org/entity/Q37338263

about

Aging, cancer, and cancer vaccines

P2860

Q42172986-A70177FD-8D38-428B-9272-BF9976BE82AC

P2860

Toxicity of targeted therapies in elderly patients.

http://www.wikidata.org/entity/Q37338263

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Toxicity of targeted therapies in elderly patients.

@en

Toxicity of targeted therapies in elderly patients.

@nl

type

label

Toxicity of targeted therapies in elderly patients.

@en

Toxicity of targeted therapies in elderly patients.

@nl

prefLabel

Toxicity of targeted therapies in elderly patients.

@en

Toxicity of targeted therapies in elderly patients.

@nl

P1433

Q37338263-958E06CE-1D3F-40FD-A1F9-D7D004EAB9FA

P1476

Q37338263-788374A6-27DA-4340-A09B-2D9A0B56EAAD

P2093

Q37338263-20837F45-9228-4893-871B-83407EDFAFE5

Q37338263-2461FFC6-64C5-4444-AD56-BED97C75C3CA

Q37338263-9DFA8B33-9C05-48D0-9616-9EE5B1B66424

P2860

Q37338263-083B13F8-D33C-4DC1-AEAF-E764C1FA8AF9

Q37338263-0F6E3E9B-0F4C-47C0-B9F7-9B0E89FBE9BD

Q37338263-1BF18105-53CA-4DB8-B212-D1F0FC0B6BB4

Q37338263-1D84FF27-39FC-408B-83E4-B89534A3F782

Q37338263-2A05A493-4533-4423-8E16-D83B0AFE5F6F

Q37338263-32388AE2-BB6D-4F59-9538-58A3BDDA14DD

Q37338263-387C622D-7265-49B0-8A5E-F1217B56F4C8

Q37338263-439193F8-ADCA-424B-97AE-4EE5D38E6412

Q37338263-4D07770C-39B7-497A-850E-8026A35D66F6

Q37338263-505DB4DF-B35E-48A9-A84E-019D7AE22FD2

P304

Q37338263-B62E97D8-B222-4F7D-9328-E2CD10DFC2ED

P31

Q37338263-3E06E8A6-8417-49AC-B21B-E512FAACD9E0

P356

Q37338263-64228D42-35F4-47AC-9DA8-17F0B300602B

P433

Q37338263-86451B50-A21B-4FB6-B20A-C0190AB8273C

P478

Q37338263-4EBE0597-9F9C-4920-BDF3-AADFE23DFC57

P577

Q37338263-CC6D2E7A-871C-47AB-AD7D-91B67270CD63

P698

Q37338263-F00E3D60-0D15-404F-AC39-D6BCAB9DE47C

P356

14737140.8.12.1965

P1433

Expert Review of Anticancer Therapy

P1476

Toxicity of targeted therapies in elderly patients.

@en

P2093

F Petrelli

http://www.w3.org/2001/XMLSchema#string

Mary Cabiddu

http://www.w3.org/2001/XMLSchema#string

Sandro Barni

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Sorafenib in advanced clear-cell renal-cell carcinoma

Erlotinib in previously treated non-small-cell lung cancer

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

P304

1965-1976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.12.1965

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19046116

http://www.w3.org/2001/XMLSchema#string